Cytation 9 multimode reader or equal instrument

The US Food and Drug Administration (FDA) is seeking a Cytation 9 multimode reader or an equal instrument to support a wide range of bacterial assays. The required instrument should have variable bandwidth monochromator-based detection modes, including UV-Vis absorbance, fluorescence, and luminescence. The instrument should also have the ability to conduct direct nucleic acid quantification, have a fluorescence excitation/emission wavelength range, and be able to control and read endpoint and kinetic assay studies. The FDA requires a new instrument that meets all the technical requirements specified in the solicitation. Some key features of the required instrument include: • Variable bandwidth monochromator-based detection modes • Absorbance readings of 230-999 nm with a dynamic range between 0 – 4.0 OD • Ability to conduct direct nucleic acid quantification in microvolume samples • Fluorescence excitation/emission wavelength range of 250-700 nm • Luminescence detection range of 300-700 nm The selected vendor will be responsible for providing a turn-key solution, including all hardware, software, and training necessary to meet the FDA's requirements.